Insmed Inc’s recent filing unveils that its Chief Legal Officer Smith Michael Alexander unloaded Company’s shares for reported $2.07 million on Sep 13 ’24. In the deal valued at $74.35 per share,27,871 shares were sold. As a result of this transaction, Smith Michael Alexander now holds 67,856 shares worth roughly $4.82 million.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, Flammer Martina M.D. sold 26,969 shares, generating $2,019,978 in total proceeds. Upon selling the shares at $74.90, the Chief Medical Officer now owns 106,134 shares.
Before that, Flammer Martina M.D. sold 13,436 shares. Insmed Inc shares valued at $1,006,625 were divested by the Chief Medical Officer at a price of $74.92 per share. As a result of the transaction, Flammer Martina M.D. now holds 106,134 shares, worth roughly $7.53 million.
Truist initiated its Insmed Inc [INSM] rating to a Buy in a research note published on April 23, 2024; the price target was $48. A number of analysts have revised their coverage, including Wolfe Research’s analysts, who began to cover the stock in mid February with a ‘”an Outperform”‘ rating. Wells Fargo began covering INSM with “an Overweight” recommendation on December 08, 2023.
Price Performance Review of INSM
On Friday, Insmed Inc [NASDAQ:INSM] saw its stock fall -1.05% to $70.96. Over the last five days, the stock has lost -4.80%. Insmed Inc shares have risen nearly 128.98% since the year began. Nevertheless, the stocks have risen 178.82% over the past one year. While a 52-week high of $80.53 was reached on 08/22/24, a 52-week low of $21.92 was recorded on 05/24/24. SMA at 50 days reached $73.82, while 200 days put it at $50.26.
Levels Of Support And Resistance For INSM Stock
The 24-hour chart illustrates a support level at 70.36, which if violated will result in even more drops to 69.77. On the upside, there is a resistance level at 71.98. A further resistance level may holdings at 73.00. The Relative Strength Index (RSI) on the 14-day chart is 43.38, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -1.56, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 78.19%. Stochastics %K at 28.50% indicates the stock is a holding.
How much short interest is there in Insmed Inc?
A steep rise in short interest was recorded in Insmed Inc stocks on 2024-10-15, growing by 1.48 million shares to a total of 13.7 million shares. Yahoo Finance data shows the prior-month short interest on 2024-09-13 was 12.22 million shares. There was a rise of 10.8%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on July 26, 2023 when Guggenheim began covering the stock and recommended ‘”a Buy”‘ rating along with a $50 price target.
